LivaNova (NASDAQ:LIVN) Cut to Buy at StockNews.com

StockNews.com downgraded shares of LivaNova (NASDAQ:LIVN) from a strong-buy rating to a buy rating in a research note released on Wednesday morning.

A number of other brokerages have also issued reports on LIVN. Needham & Company LLC dropped their price target on shares of LivaNova from $75.00 to $64.00 and set a “buy” rating for the company in a research note on Wednesday. Robert W. Baird lifted their price target on shares of LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a research note on Thursday, October 31st. Wolfe Research lowered shares of LivaNova from an “outperform” rating to a “peer perform” rating in a research note on Wednesday. Stifel Nicolaus lowered their target price on shares of LivaNova from $72.00 to $60.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Mizuho lowered their target price on shares of LivaNova from $70.00 to $60.00 and set an “outperform” rating for the company in a research note on Wednesday. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, LivaNova currently has an average rating of “Buy” and an average target price of $64.20.

LivaNova Stock Up 1.7 %

Shares of NASDAQ:LIVN opened at $41.63 on Wednesday. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. The company has a fifty day simple moving average of $47.40 and a 200 day simple moving average of $49.49. The firm has a market cap of $2.26 billion, a PE ratio of 99.12 and a beta of 1.00. LivaNova has a 12-month low of $40.37 and a 12-month high of $64.47.

Insider Buying and Selling at LivaNova

In other news, Director Francesco Bianchi sold 1,250 shares of the company’s stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $50.99, for a total transaction of $63,737.50. Following the completion of the transaction, the director now owns 7,522 shares in the company, valued at approximately $383,546.78. This represents a 14.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.27% of the stock is owned by insiders.

Hedge Funds Weigh In On LivaNova

Institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. grew its position in shares of LivaNova by 17.1% during the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock worth $70,000 after acquiring an additional 219 shares during the last quarter. Sterling Capital Management LLC grew its position in shares of LivaNova by 800.6% during the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock worth $75,000 after acquiring an additional 1,441 shares during the last quarter. Central Pacific Bank Trust Division grew its position in shares of LivaNova by 21.2% during the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock worth $191,000 after acquiring an additional 720 shares during the last quarter. Vestcor Inc bought a new position in shares of LivaNova during the fourth quarter worth about $204,000. Finally, Optimize Financial Inc bought a new position in shares of LivaNova during the fourth quarter worth about $208,000. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.